Lombard Medical postpones $60 million IPO

By Renaissance Capital,

Shutterstock photo

Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, postponed its IPO on Friday, citing poor market conditions. The Oxfordshire, United Kingdom-based company was founded in 2003 and booked $7 million in sales for the 12 months ended 12/31/2013. Lombard Medical initially filed confidentially on 1/22/2014. Jefferies & Co. and Barclays were set to be the joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines IPOs
Referenced Stocks: EVAR

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com